Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Cellarity is raising $121,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Fabrice Chouraqui played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cellarity
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of disease, enabling a quantum leap in the success rate and speed of drug discovery.

To learn more about Cellarity, visit http://www.cellarity.com/

Contact:
Fabrice Chouraqui, Chief Executive Officer
617-500-7775

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved